Sensing Biology Where It Matters: A Distributed Diagnostic Infrastructure
ABSTRACT
Biological testing remains heavily dependent on centralized laboratories, complex optical instruments, and workflows that can delay decisions by days or weeks. Yet many of the most consequential biological risks arise in places where immediate action matters: food-processing facilities, farms, water systems, veterinary settings, hospitals, environmental monitoring sites, and distributed field operations including defense.
SensTek is developing a distributed diagnostic infrastructure designed to bring molecular diagnostics closer to the point-of-need. The platform, based on a proprietary solid-state electrochemical sensor technology, combines a reusable electronic reader, disposable multi-reaction-chamber cartridges, application-specific molecular assays, mobile app, cloud dashboards and AI-enabled analytics. Its direct electrochemical bio-sensing architecture captures bioreaction kinetics without relying on conventional optical detection, enabling compact instrumentation, spatial multiplexing, integrated controls, and digitally native biological data.
This presentation will explore how SensTek is transforming molecular testing from a stand-alone laboratory procedure into a scalable bio-sensing and decision infrastructure. It will examine the technology architecture, market need, commercialization model, and manufacturing ecosystem required to deploy biological sensing across multiple industries.
BIOGRAPHY
Manny Singh is CEO and Cofounder of SensTek Diagnostics (www.senstekdx.com), a Distributed Diagnostic Infrastructure company headquartered in Oakland, CA.
SensTek’s Universal Diagnostics platform combines reusable electronic readers, disposable multi-reaction-chamber cartridges, molecular assays, mobile app, cloud dashboard and AI-enabled analytics to bring biological sensing closer to the point of need. The company is developing nucleic acid testing and immunoassay testing across food safety, agriculture, water quality, animal health, blood safety, environmental monitoring, defense, and healthcare.
Under his leadership, SensTek has advanced its sensor technology, intellectual property, manufacturing strategy, commercialization partnerships, and market-specific licensing models. His focus is on transforming biological testing from a centralized, instrument-intensive process into a scalable diagnostics bio-sensing infrastructure capable of generating real-time, actionable biological intelligence.
Manny Singh holds MSEE from SJSU and BSEE from UC Davis. He has over 2 decades of experience in semiconductor, technology, sensors, AI/ML/analytics that spans across design, application, marketing, business unit functions. He holds 18 patents, recipient of Marquis Who’s Who award in 2025, and has multiple publications.